ID   LOHG-F
AC   CVCL_LI09
DR   Wikidata; Q54902880
RX   PubMed=10375592;
RX   PubMed=15753990;
CC   Population: Caucasian.
CC   Senescence: Senesces at 34 PDL (PubMed=15753990).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Thr215Serfs*13 (c.643_646delACAG); ClinVar=VCV000200997; Zygosity=Unspecified (PubMed=10375592).
DI   NCIt; C3225; Multiple endocrine neoplasia type 1
DI   NCIt; C5394; Solitary adult fibroma
DI   ORDO; Orphanet_652; Multiple endocrine neoplasia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LI10 ! LOHG-I
OI   CVCL_LI11 ! LOHG-L
OI   CVCL_LI12 ! LOHG-NSA
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 10
//
RX   PubMed=10375592; DOI=10.3892/ijo.15.1.41;
RA   Sigl E., Behmel A., Henn T., Wirnsberger G.H., Weinhausl A., Kaserer K.,
RA   Niederle B., Pfragner R.;
RT   "Cytogenetic and CGH studies of four neuroendocrine tumors and
RT   tumor-derived cell lines of a patient with multiple endocrine
RT   neoplasia type 1.";
RL   Int. J. Oncol. 15:41-51(1999).
//
RX   PubMed=15753990; DOI=10.3892/ijo.26.4.961;
RA   Voglauer R., Grillari J., Fortschegger K., Wieser M., Sterovsky T.,
RA   Gunsberg P., Katinger H., Pfragner R.;
RT   "Establishment of human fibroma cell lines from a MEN1 patient by
RT   introduction of either hTERT or SV40 early region.";
RL   Int. J. Oncol. 26:961-970(2005).
//